Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Olema Pharmaceuticals, Inc. (OLMA) had Weighted-Average Shares Outstanding (Diluted) of 85.73M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-42.22M |
|
-- |
|
-- |
|
$45.88M |
|
$-45.88M |
|
$3.66M |
|
$-42.22M |
|
$-42.22M |
|
$-42.22M |
|
$-42.22M |
|
$-42.22M |
|
$-42.22M |
|
$-45.88M |
|
$-45.83M |
|
85.73M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
85.73M |
$-0.49 |
|
$-0.49 |
|
| Balance Sheet Financials | |
$334.33M |
|
-- |
|
$18.12M |
|
$352.45M |
|
$41.66M |
|
$3.00M |
|
$3.31M |
|
$44.97M |
|
$307.49M |
|
$307.49M |
|
$307.49M |
|
68.65M |
|
| Cash Flow Statement Financials | |
$-108.39M |
|
$6.42M |
|
$-2.25M |
|
$139.48M |
|
$35.26M |
|
$-104.22M |
|
$13.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.03 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-108.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.73% |
|
-13.73% |
|
-11.98% |
|
-13.60% |
|
$4.48 |
|
$-1.26 |
|
$-1.26 |
|